Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer

New Strategies in Lung Cancer: Translating Immunotherapy into Clinical Practice

(2014) Patrick M. Forde et al.   CLINICAL CANCER RESEARCH

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

(2014) Yuankai Shi et al.   Journal of Thoracic Oncology

Combining COPD with Clinical, Pathological and Demographic Information Refines Prognosis and Treatment Response Prediction of Non-Small Cell Lung Cancer

(2014) Joseph Putila et al.   PLoS One

A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease

(2013) M. L. Disis et al.   Cancer Prevention Research

Long-term Residential Exposure to Air Pollution and Lung Cancer Risk

(2013) Perry Hystad et al.   EPIDEMIOLOGY

Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

(2013) Chee Khoon Lee et al.   JNCI-Journal of the National Cancer Institute

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

(2013) E. A. Akbay et al.   Cancer Discovery

Quantitative monitoring of mouse lung tumors by magnetic resonance imaging

(2012) Alexander Sasha Krupnick et al.   Nature Protocols

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial

(2011) P. F. Brunsvig et al.   CLINICAL CANCER RESEARCH

Lung Cancer Incidence and Long-Term Exposure to Air Pollution from Traffic

(2011) Ole Raaschou-Nielsen et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

HER-2/neu as a target for cancer vaccines

(2010) Constantin N Baxevanis et al.   Immunotherapy

Insulin-like Growth Factor-Binding Protein-2 Is a Target for the Immunomodulation of Breast Cancer

(2008) K. H. Park et al.   CANCER RESEARCH